HL 3.39 Hecla Mining Company $HL stock added to my watch

Fresh Blood at the Helm: Tim Cox's New Role BMO's leadership is getting a shakeup worthy of any Wall Street drama. Tim Cox, a name insiders hail for his sharp legal mind and strategic chops, is stepping up as the U.S. Country Head for BMO. Come November 1st, he'll be steering BMO's massive U.S. subsidiaries like BMO Financial Corp. and BMO Bank N.A. It's a big leap from...

A Long Path to Connection Sometimes it's easy to forget the power a community can wield until you see one rally around a cause. The launch of ALS.Community isn't just a digital debut; it's a testament to how collective understanding can be a lifeline. For folks grappling with amyotrophic lateral sclerosis (ALS), beating solitude is often half the battle. Founder Jeff...

Breaking Through the Noise in B2B Nobody today would be shocked to hear business owners are practically drowning in options when it comes to B2B service providers. But amid this noisy sea, TrewUp has managed to shout louder than the rest by grabbing a 2026 Inc. Power Partner Awards win—for the second year in a row, no less. It seems like they’ve cracked some sort of...

Another Day, Another Lawsuit Nothing says 'start your week' quite like the sounds of courtroom battles echoing across the market landscape. Baidu, Inc. (NASDAQ: BIDU) finds itself in the legal crosshairs, courtesy of the DJS Law Group. They're being accused of some shady dealings, and the core of this drama is all about what they claimed versus the reality of their...

Doximity's Legal Storm: A Rocky Road Ahead? Here's the deal, folks. Doximity, a name some might've thrown around in digital health conclaves, is now wrapped up in a mire of legal woes. Those tricky waters come courtesy of a securities class action lawsuit—all about overstated growth prospects that took some investors by surprise. What's Got Investors Peeved? Investors...

A Call for Congressional Accountability The American Center for Cures is banging the drum for change, and they're banging it loud. Founded by Lou Weisbach, this group has come out swinging, urging Americans to slap disease onto the ballot in the midterms. Why? Because dealing with Alzheimer's, diabetes, heart disease, and cancer every year rips a whopping $1.1 trillion...

Home Remodeling: More Than Just a Facelift Ah, the prospect of turning your house into your dream home—sounds idyllic until you're knee-deep in dusty chaos. Remodeling isn't a walk in the park; it's a marathon filled with pitfalls and rollercoaster emotions. According to Brian Ward from Ward Construction & Remodeling, the process has set stages, and knowing these can...

No Surprises Here—M&T Pays Out Big On Preferreds If there's one thing the market just loves to see amid all this noise and chatter, it's cash coming back to shareholders. M&T Bank Corporation, a seasoned player in the financial sector, is keeping its shareholders happy with some neat quarterly preferred stock dividends. Now, if you've been poking around the NYSE:MTB...

Reading the Fine Print in VW Leasing's Latest Move Let's get right into the weeds: Volkswagen Leasing's cranking out MXN 2.5 billion in long-term debt certificates. This maneuver ain't happening in a vacuum—it's powered by the intricate levers behind Greenberg Traurig's sharp legal mind. This isn't just another financial transaction; it's a strategically framed...

Are Shareholders Getting the Short End of the Stick? Ever feel like the small fish in a big corporate pond? That's the scene unfolding with EFSI, VCTR, and CSR shareholders wondering if they're getting a fair shake. The potential here smells like a fat payday for insiders, while ordinary investors might just be scraping for crumbs. Let's dig into this mess. Under the...

Changes to the Co-Primary Endpoint in the SENTRY Trial Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a pharmaceutical company committed to advancing innovative cancer therapies, has made a crucial adjustment in their Phase 3 SENTRY trial focusing on myelofibrosis. Following valuable feedback from the U.S. Food and Drug Administration (FDA), the company is shifting the...

First Citizens BancShares Announces Upcoming Earnings Call First Citizens BancShares, Inc. (NASDAQ: FCNCA) has exciting news to share with its investors. The company has officially announced its plan to report financial results for the fiscal quarter that ended June 30, 2025. The announcement is set to be made before the financial markets open on Friday. Details of the...

Cineverse and Air Bud Entertainment Announce National Talent Search One of Hollywood's Most Enduring Family Film Franchises Returns to Theaters in Summer 2026 Cineverse (NASDAQ: CNVS), a next-generation entertainment studio, alongside Air Bud Entertainment, is thrilled to declare the commencement of a nationwide talent search. This initiative seeks to find the next golden...

Examining Apple's Position in Technology Hardware In a fast-evolving technology landscape, a thorough analysis of companies is essential for investors and business enthusiasts. This article will explore Apple Inc. (NASDAQ: AAPL) and how it fits into the dynamic Technology Hardware, Storage & Peripherals industry. By analyzing significant financial ratios and market...

Introducing Vystar’s Revitalized Digital Presence Vystar Corporation (OTCQB: VYST), a leading name in innovative comfort solutions, has taken a bold step forward by launching a freshly redesigned website. With a cleaner look and improved functionality, the new site serves as a vital element of the company's comprehensive digital strategy and brand refresh. Customers can...